Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca has seen his ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

New documents have investigators questioning inconsistencies and omissions in data reporting in the PLATO trial, building on ...

SAN ANTONIO -- The addition of palbociclib (Ibrance) to current standard-of-care therapy following induction chemotherapy ...

Among more than 5,000 patients followed for a median of roughly 8 years, bilateral risk-reducing mastectomy (RRM) was ...

AstraZeneca and Daiichi Sankyo shared the pooled analysis behind the refiling of their TROP2 antibody-drug conjugate (ADC) ...

In a report released on December 11, David Evans from Kepler Capital maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...

A new report questions the efficacy of a drug approved by the FDA to help precent heart attack and stroke in people with a ...

Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Most positive tests for RSV so far this season in Canada have been among the youngest, federal data suggests. And while ...

Conduit Pharmaceuticals has signed an agreement with Sarborg to leverage advanced AI and cybernetics for the optimisation of processes related to key drug development. These include the repurposing ...